跳至主要内容
临床试验/NL-OMON33481
NL-OMON33481尚未招募不适用

Prediction of radiation induced lung damage based on dose distribution and tumour location. A pilot study. - RT2009-06

niversitair Medisch Centrum Groningen0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • . Age > 18 years
  • . WHO PS 0-2
  • . Stage IIIA/IIIB Non Small Cell Lung Cancer (NSCLC). Planned for conventionally fractionated radiotherapy with or without concomitant chemotherapy, 51-60 Gy.
  • . Limited disease Small Cell Lung Cancer, i.e. tumor confined to hemithorax without evidence of distant metastases or malignant pleural effusion. Planned for conventionally fractionated (chemo)radiotherapy, 45 Gy.
  • . Adequate pulmonary function
  • . Life expectancy of at least 6 months
  • .. Before patient registration, informed consent must be given

排除标准

  • . WHO PS=3
  • . Life expectancy less than 6 months

研究者

相似试验